Concepts (227)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Palliative Care | 25 | 2025 | 432 | 3.570 |
Why?
|
| Parents | 28 | 2025 | 1024 | 2.490 |
Why?
|
| Neoplasms | 31 | 2024 | 2790 | 1.980 |
Why?
|
| Truth Disclosure | 9 | 2020 | 102 | 1.580 |
Why?
|
| Medical Oncology | 6 | 2023 | 220 | 1.100 |
Why?
|
| Physician-Patient Relations | 6 | 2020 | 427 | 1.070 |
Why?
|
| Communication | 9 | 2023 | 507 | 1.000 |
Why?
|
| Chronic Disease | 8 | 2023 | 1187 | 0.990 |
Why?
|
| Terminally Ill | 4 | 2015 | 28 | 0.960 |
Why?
|
| Decision Making | 9 | 2019 | 656 | 0.860 |
Why?
|
| Physicians | 6 | 2020 | 581 | 0.790 |
Why?
|
| Stress, Psychological | 9 | 2025 | 550 | 0.750 |
Why?
|
| Trust | 2 | 2020 | 76 | 0.690 |
Why?
|
| Quality of Life | 13 | 2023 | 1907 | 0.640 |
Why?
|
| Benchmarking | 1 | 2019 | 137 | 0.590 |
Why?
|
| Emotions | 3 | 2019 | 348 | 0.580 |
Why?
|
| Child | 50 | 2025 | 24609 | 0.570 |
Why?
|
| Hospitals, Pediatric | 10 | 2020 | 768 | 0.520 |
Why?
|
| Surveys and Questionnaires | 17 | 2020 | 3674 | 0.500 |
Why?
|
| Prognosis | 14 | 2023 | 4683 | 0.430 |
Why?
|
| Hematologic Neoplasms | 1 | 2015 | 277 | 0.370 |
Why?
|
| Child, Preschool | 33 | 2025 | 14150 | 0.370 |
Why?
|
| Nursing Staff, Hospital | 2 | 2011 | 60 | 0.340 |
Why?
|
| Male | 46 | 2025 | 61429 | 0.320 |
Why?
|
| Parent-Child Relations | 4 | 2019 | 248 | 0.310 |
Why?
|
| Female | 46 | 2025 | 66669 | 0.300 |
Why?
|
| Adult | 26 | 2025 | 29452 | 0.290 |
Why?
|
| Pediatrics | 2 | 2015 | 1158 | 0.290 |
Why?
|
| Adolescent | 30 | 2025 | 19412 | 0.290 |
Why?
|
| Hope | 3 | 2018 | 13 | 0.280 |
Why?
|
| Infant | 25 | 2023 | 12610 | 0.280 |
Why?
|
| Humans | 57 | 2025 | 125025 | 0.280 |
Why?
|
| Professional-Family Relations | 5 | 2017 | 93 | 0.280 |
Why?
|
| Prospective Studies | 13 | 2025 | 6122 | 0.280 |
Why?
|
| 3-Iodobenzylguanidine | 2 | 2004 | 12 | 0.270 |
Why?
|
| Self Report | 3 | 2018 | 508 | 0.270 |
Why?
|
| Symptom Assessment | 3 | 2025 | 101 | 0.260 |
Why?
|
| Infant, Newborn | 19 | 2021 | 8272 | 0.260 |
Why?
|
| Patient Preference | 2 | 2017 | 118 | 0.250 |
Why?
|
| Fatigue | 2 | 2018 | 188 | 0.250 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2015 | 847 | 0.250 |
Why?
|
| Child Welfare | 2 | 2017 | 65 | 0.240 |
Why?
|
| Pain | 4 | 2015 | 447 | 0.240 |
Why?
|
| Social Support | 3 | 2018 | 340 | 0.240 |
Why?
|
| Residence Characteristics | 1 | 2007 | 270 | 0.240 |
Why?
|
| Proxy | 1 | 2025 | 19 | 0.230 |
Why?
|
| Longitudinal Studies | 5 | 2020 | 1320 | 0.230 |
Why?
|
| Poverty | 3 | 2024 | 420 | 0.230 |
Why?
|
| Hospitals | 1 | 2007 | 391 | 0.230 |
Why?
|
| Income | 3 | 2024 | 132 | 0.220 |
Why?
|
| Attitude of Health Personnel | 3 | 2017 | 668 | 0.220 |
Why?
|
| Terminal Care | 3 | 2015 | 112 | 0.210 |
Why?
|
| Follow-Up Studies | 8 | 2020 | 5167 | 0.210 |
Why?
|
| Radiopharmaceuticals | 1 | 2003 | 168 | 0.200 |
Why?
|
| Middle Aged | 13 | 2020 | 26670 | 0.200 |
Why?
|
| Anxiety | 3 | 2024 | 944 | 0.190 |
Why?
|
| Neuroblastoma | 2 | 2004 | 529 | 0.190 |
Why?
|
| Caregivers | 2 | 2018 | 540 | 0.180 |
Why?
|
| United States | 8 | 2021 | 10884 | 0.170 |
Why?
|
| Antineoplastic Agents | 3 | 2015 | 1714 | 0.170 |
Why?
|
| Continuity of Patient Care | 2 | 2015 | 150 | 0.160 |
Why?
|
| Analgesics, Opioid | 2 | 2014 | 409 | 0.160 |
Why?
|
| Cohort Studies | 9 | 2023 | 4819 | 0.160 |
Why?
|
| Home Care Services | 2 | 2012 | 74 | 0.160 |
Why?
|
| Cranial Irradiation | 1 | 2019 | 69 | 0.160 |
Why?
|
| Patient Care Planning | 2 | 2023 | 121 | 0.160 |
Why?
|
| Family | 3 | 2021 | 562 | 0.150 |
Why?
|
| Philadelphia | 5 | 2017 | 27 | 0.150 |
Why?
|
| Workload | 1 | 2019 | 147 | 0.150 |
Why?
|
| Proton Therapy | 1 | 2019 | 126 | 0.140 |
Why?
|
| Depression | 2 | 2024 | 1233 | 0.140 |
Why?
|
| Patient Care | 1 | 2018 | 100 | 0.140 |
Why?
|
| Cross-Sectional Studies | 7 | 2024 | 3402 | 0.140 |
Why?
|
| Health Communication | 1 | 2017 | 27 | 0.140 |
Why?
|
| Attitude to Death | 2 | 2007 | 37 | 0.130 |
Why?
|
| Access to Information | 1 | 2017 | 40 | 0.130 |
Why?
|
| Patient Protection and Affordable Care Act | 2 | 2015 | 64 | 0.130 |
Why?
|
| Hospitalization | 3 | 2014 | 1783 | 0.130 |
Why?
|
| Attitude to Health | 1 | 2018 | 255 | 0.130 |
Why?
|
| Problem Solving | 2 | 2013 | 63 | 0.130 |
Why?
|
| Survivors | 1 | 2018 | 339 | 0.120 |
Why?
|
| Carboplatin | 1 | 2015 | 77 | 0.120 |
Why?
|
| Irritable Mood | 1 | 2015 | 9 | 0.120 |
Why?
|
| Cerebellar Neoplasms | 1 | 2019 | 443 | 0.120 |
Why?
|
| Family Health | 1 | 2015 | 256 | 0.110 |
Why?
|
| Siblings | 1 | 2015 | 186 | 0.110 |
Why?
|
| Medulloblastoma | 1 | 2019 | 548 | 0.110 |
Why?
|
| Prevalence | 5 | 2024 | 2458 | 0.110 |
Why?
|
| Advance Care Planning | 1 | 2015 | 38 | 0.110 |
Why?
|
| Conscious Sedation | 1 | 2014 | 58 | 0.110 |
Why?
|
| Logistic Models | 2 | 2016 | 1800 | 0.110 |
Why?
|
| Antiemetics | 1 | 2014 | 22 | 0.110 |
Why?
|
| Drug Hypersensitivity | 1 | 2015 | 96 | 0.110 |
Why?
|
| Nausea | 1 | 2014 | 84 | 0.110 |
Why?
|
| Senna Extract | 1 | 2013 | 1 | 0.110 |
Why?
|
| Iodine Radioisotopes | 2 | 2004 | 74 | 0.110 |
Why?
|
| Goals | 1 | 2014 | 126 | 0.110 |
Why?
|
| Cathartics | 1 | 2013 | 28 | 0.110 |
Why?
|
| Child Behavior | 1 | 2015 | 230 | 0.110 |
Why?
|
| Vomiting | 1 | 2014 | 103 | 0.110 |
Why?
|
| Hypnotics and Sedatives | 1 | 2014 | 133 | 0.110 |
Why?
|
| Young Adult | 9 | 2021 | 9054 | 0.110 |
Why?
|
| Constipation | 1 | 2013 | 114 | 0.100 |
Why?
|
| Judgment | 1 | 2013 | 36 | 0.100 |
Why?
|
| Fathers | 1 | 2013 | 69 | 0.100 |
Why?
|
| Central Nervous System Neoplasms | 1 | 2015 | 209 | 0.100 |
Why?
|
| Hospice Care | 1 | 2012 | 31 | 0.090 |
Why?
|
| Patient-Centered Care | 1 | 2014 | 220 | 0.090 |
Why?
|
| Acute Disease | 1 | 2015 | 1095 | 0.090 |
Why?
|
| Health Care Costs | 1 | 2015 | 371 | 0.090 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2014 | 316 | 0.090 |
Why?
|
| Quality of Health Care | 1 | 2014 | 390 | 0.090 |
Why?
|
| Bereavement | 1 | 2011 | 19 | 0.090 |
Why?
|
| Eligibility Determination | 1 | 2011 | 37 | 0.090 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2017 | 729 | 0.090 |
Why?
|
| Societies, Medical | 1 | 2015 | 700 | 0.090 |
Why?
|
| Medical Audit | 1 | 2011 | 98 | 0.090 |
Why?
|
| Intensive Care Units, Pediatric | 1 | 2014 | 479 | 0.090 |
Why?
|
| Complementary Therapies | 1 | 2011 | 41 | 0.090 |
Why?
|
| Disease Progression | 4 | 2018 | 2083 | 0.090 |
Why?
|
| Glioma | 1 | 2015 | 513 | 0.090 |
Why?
|
| Mothers | 1 | 2013 | 356 | 0.080 |
Why?
|
| Health Personnel | 1 | 2014 | 506 | 0.080 |
Why?
|
| Health Services Accessibility | 1 | 2015 | 605 | 0.080 |
Why?
|
| Salvage Therapy | 1 | 2011 | 185 | 0.080 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2014 | 522 | 0.080 |
Why?
|
| Retrospective Studies | 8 | 2015 | 16334 | 0.080 |
Why?
|
| Critical Illness | 1 | 2013 | 599 | 0.070 |
Why?
|
| Spirituality | 1 | 2007 | 48 | 0.070 |
Why?
|
| Community-Institutional Relations | 1 | 2007 | 30 | 0.070 |
Why?
|
| Electronic Health Records | 1 | 2014 | 721 | 0.070 |
Why?
|
| Nurse-Patient Relations | 1 | 2007 | 17 | 0.070 |
Why?
|
| Patient Reported Outcome Measures | 2 | 2018 | 164 | 0.070 |
Why?
|
| Boston | 2 | 2017 | 109 | 0.060 |
Why?
|
| Health Services Needs and Demand | 1 | 2007 | 171 | 0.060 |
Why?
|
| Data Collection | 1 | 2007 | 378 | 0.060 |
Why?
|
| Housing | 1 | 2024 | 53 | 0.060 |
Why?
|
| WAGR Syndrome | 1 | 2003 | 7 | 0.060 |
Why?
|
| Treatment Outcome | 6 | 2015 | 12269 | 0.050 |
Why?
|
| Adaptation, Psychological | 2 | 2015 | 429 | 0.040 |
Why?
|
| Blood Platelets | 1 | 2003 | 325 | 0.040 |
Why?
|
| Survival Rate | 2 | 2019 | 2051 | 0.040 |
Why?
|
| Pilot Projects | 2 | 2015 | 1395 | 0.040 |
Why?
|
| Neoplasm Staging | 1 | 2003 | 1275 | 0.040 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2024 | 1114 | 0.040 |
Why?
|
| Radiotherapy Planning, Computer-Assisted | 1 | 2019 | 63 | 0.040 |
Why?
|
| Psychology, Child | 1 | 2019 | 43 | 0.040 |
Why?
|
| Information Seeking Behavior | 1 | 2018 | 15 | 0.040 |
Why?
|
| Cancer Pain | 1 | 2018 | 24 | 0.040 |
Why?
|
| Parental Notification | 1 | 2017 | 2 | 0.040 |
Why?
|
| Family Characteristics | 1 | 2018 | 80 | 0.040 |
Why?
|
| Technology | 1 | 2018 | 64 | 0.040 |
Why?
|
| Cross-Cultural Comparison | 1 | 2018 | 57 | 0.040 |
Why?
|
| Oncologists | 1 | 2017 | 28 | 0.040 |
Why?
|
| Social Class | 1 | 2018 | 190 | 0.030 |
Why?
|
| Risk Factors | 3 | 2018 | 10278 | 0.030 |
Why?
|
| Age of Onset | 1 | 2019 | 600 | 0.030 |
Why?
|
| Cost of Illness | 1 | 2018 | 251 | 0.030 |
Why?
|
| Child Health | 1 | 2017 | 56 | 0.030 |
Why?
|
| Academic Medical Centers | 1 | 2017 | 308 | 0.030 |
Why?
|
| Health Status Disparities | 1 | 2018 | 228 | 0.030 |
Why?
|
| Desensitization, Psychologic | 1 | 2015 | 6 | 0.030 |
Why?
|
| Histamine H1 Antagonists | 1 | 2015 | 13 | 0.030 |
Why?
|
| Washington | 1 | 2015 | 32 | 0.030 |
Why?
|
| Sleep Stages | 1 | 2015 | 32 | 0.030 |
Why?
|
| Histamine H2 Antagonists | 1 | 2015 | 50 | 0.030 |
Why?
|
| Parenting | 1 | 2019 | 333 | 0.030 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2015 | 100 | 0.030 |
Why?
|
| Patient Dropouts | 1 | 2015 | 52 | 0.030 |
Why?
|
| Vincristine | 1 | 2015 | 191 | 0.030 |
Why?
|
| Aged | 1 | 2012 | 19653 | 0.030 |
Why?
|
| Neoplasm Grading | 1 | 2015 | 276 | 0.030 |
Why?
|
| Life Expectancy | 1 | 2014 | 53 | 0.030 |
Why?
|
| Comprehension | 1 | 2014 | 74 | 0.030 |
Why?
|
| Sickness Impact Profile | 1 | 2014 | 35 | 0.030 |
Why?
|
| Psychometrics | 1 | 2017 | 647 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2017 | 1252 | 0.030 |
Why?
|
| Patient Satisfaction | 1 | 2017 | 470 | 0.030 |
Why?
|
| Aphorisms and Proverbs as Topic | 1 | 2013 | 1 | 0.030 |
Why?
|
| Anxiety Disorders | 1 | 2019 | 689 | 0.030 |
Why?
|
| Patient Care Team | 2 | 2007 | 542 | 0.030 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2015 | 319 | 0.030 |
Why?
|
| Feedback | 1 | 2014 | 162 | 0.030 |
Why?
|
| Psychological Tests | 1 | 2013 | 90 | 0.030 |
Why?
|
| Interview, Psychological | 1 | 2013 | 98 | 0.020 |
Why?
|
| Nursing, Private Duty | 1 | 2012 | 1 | 0.020 |
Why?
|
| Durable Medical Equipment | 1 | 2012 | 4 | 0.020 |
Why?
|
| Telemedicine | 1 | 2018 | 436 | 0.020 |
Why?
|
| Health Surveys | 1 | 2013 | 243 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2015 | 760 | 0.020 |
Why?
|
| Polyneuropathies | 1 | 2012 | 29 | 0.020 |
Why?
|
| Choice Behavior | 1 | 2013 | 132 | 0.020 |
Why?
|
| Life Support Care | 1 | 2012 | 48 | 0.020 |
Why?
|
| Linear Models | 1 | 2013 | 681 | 0.020 |
Why?
|
| Sex Factors | 1 | 2015 | 1275 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 2018 | 1265 | 0.020 |
Why?
|
| Patient Selection | 1 | 2015 | 693 | 0.020 |
Why?
|
| Insurance, Health | 1 | 2012 | 139 | 0.020 |
Why?
|
| Huntington Disease | 1 | 2012 | 143 | 0.020 |
Why?
|
| Religion | 1 | 2011 | 46 | 0.020 |
Why?
|
| Nurses | 1 | 2011 | 67 | 0.020 |
Why?
|
| Thinking | 1 | 2010 | 34 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2013 | 858 | 0.020 |
Why?
|
| Treatment Failure | 1 | 2011 | 335 | 0.020 |
Why?
|
| Hospital Mortality | 1 | 2014 | 1027 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2013 | 1425 | 0.020 |
Why?
|
| Neurodegenerative Diseases | 1 | 2012 | 249 | 0.020 |
Why?
|
| Biomedical Research | 1 | 2014 | 516 | 0.020 |
Why?
|
| Algorithms | 1 | 2015 | 1630 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2017 | 3422 | 0.020 |
Why?
|
| Sibling Relations | 1 | 2007 | 12 | 0.020 |
Why?
|
| Expressed Emotion | 1 | 2007 | 9 | 0.020 |
Why?
|
| Psychology | 1 | 2007 | 59 | 0.020 |
Why?
|
| Interdisciplinary Communication | 1 | 2007 | 129 | 0.020 |
Why?
|
| Pain Management | 1 | 2007 | 177 | 0.020 |
Why?
|
| Brain Neoplasms | 1 | 2015 | 1316 | 0.020 |
Why?
|
| Activities of Daily Living | 1 | 2007 | 394 | 0.010 |
Why?
|
| Chronology as Topic | 1 | 2004 | 2 | 0.010 |
Why?
|
| Radionuclide Imaging | 1 | 2004 | 149 | 0.010 |
Why?
|
| Radiation Dosage | 1 | 2004 | 135 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 2004 | 391 | 0.010 |
Why?
|
| Age Distribution | 1 | 2003 | 418 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2003 | 1017 | 0.010 |
Why?
|
| Neoplasm Metastasis | 1 | 2004 | 704 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2003 | 1496 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2003 | 1361 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2004 | 2054 | 0.010 |
Why?
|